News Gilead's twice-yearly HIV PrEP set for wider rollout The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.
News UK Biobank charts success of NHS imaging project The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers.
News New cystic fibrosis triple from Vertex backed for NHS use Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.
News Paper gives hint of Apple's thinking on AI and health Apple is looking at combining AI and behavioural measurements in its health apps, but will the tech make it to a consumer device like the Apple Watch?
News 'Diabetes Barbie' launches with medtech accessories Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.
News UK authority cracks down on weight-loss drug ads Nine adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting prescription-only drugs.
News Gilead's twice-yearly HIV PrEP set for wider rollout The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face